HuagongsheHuagongshe Chemistry Print Report · For research reference only
3-Formyl-5-isopropyl-benzoic acid → N-((S)-3-{2-ethyl-4-[5-(3-formyl-5-isopropyl-phenyl)-[1,2,4]oxadiazol-3-yl]-6-methyl-phenoxy}-2-hydroxy-propyl)-2-hydroxy-acetamide
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | 3-Formyl-5-isopropyl-benzoic acid | HCID 86650519 | — |
| Reactant | HCID 87208794 | HCID 87208794 | — |
| Reactant | HCID 178436630 | HCID 178436630 | — |
| Product | N-((S)-3-{2-ethyl-4-[5-(3-formyl-5-isopropyl-phenyl)-[1,2,4]oxadiazol-3-yl]-6-methyl-phenoxy}-2-hydroxy-propyl)-2-hydroxy-acetamide | HCID 86650518 | 7.8% |
Reaction Steps
The title compound (49 mg) was prepared in analogy to rac-N-(3-{4-[5-(3-formyl-phenyl)-[1,2,4]oxadiazol-3-yl]-2,6-dimethyl-phenoxy}-2-hydroxy-propyl)-2-hydroxy-acetamide, starting from 3-formyl-5-isopropyl-benzoic acid (250 mg, 1.30 mmol) and N—((S)-3-[2-ethyl-4-(N-hydroxycarbamimidoyl)-6-methyl-phenoxy]-2-hydroxy-propyl)-2-hydroxy-acetamide (423 mg, 1.30 mmol); LC-MS**: tR=0.90 min; [M+1]+=481.85.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US08410151B2 |
| Source dataset | uspto-grants-2013_04 |
| ORD ID | ord-c8bea71ecc86447f927821c3006fdb95 |
| Source note | uspto-grants-2013_04 |